Maintenance therapy with triple versus double immunosuppressive regimen in renal transplantation: A meta-analysis

Transplantation

Volumn 63, Issue 3, 1997, Pages 386-392

  Kunz, Regina ^a,c   Neumayer, Hans Helmut ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b HUMBOLDT UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HYPERSENSITIVITY; GRAFT FAILURE; GRAFT INFECTION; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MEDICAL INFORMATION; META ANALYSIS; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MEDLINE; MIDDLE AGED; RANDOM ALLOCATION; TREATMENT OUTCOME;

EID: 0031025766     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199702150-00010     Document Type: Article

References (34)

1. Cecka JM, Terasaki PI. The UNOS Scientific Renal Transplant Registry. In: Clinical transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1993.
2. Opelz G. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 1994; 58: 443.
3. Burke JF Jr, Pirsch JD, Ramos EL, et al. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 1994; 331: 358.
4. Byar DP. Why data bases should not replace randomized controlled trials. Biometrics 1980; 36: 337.
5. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994; 331: 365.
6. Helderman JH, van Buren DH, Amend WJ Jr, Pirsch JD. Chronic immunosuppression of the renal transplant patient. J Am Soc Nephrol 1994; 4: S2.
7. Barry JM. Immunosuppressive drugs in renal transplantation: a review of the regimens. Drugs 1992; 44: 554.
8. Briggs JD. A critical review of immunosuppressive therapy. Immunol Lett 1991; 29: 89.
9. Flechner SM. Current status of renal transplantation: patient selection, results, and immunosuppression. Urol Clin North Am 1994; 21: 265.
10. DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987; 6: 341.
11. Peto R. Why do we need systematic overviews of randomized trials? Stat Med 1987; 6: 233.
12. Oxman AD, Stachenko SJ. Meta-analysis in primary care: theory and practice. In: Tudiver F, Bass MJ, Dunn EV, Norton PG, Stewart M, eds. Assessing interventions: traditional and innovative methods. Research methods for primary care. Newbury Park, CA: Sage Publications, 1992: 191.
13. Brinker KR, Dickerman RM, Gonwa TA, et al. A randomized trial comparing double-drug and triple-drug therapy in primary cadaveric renal transplants. Transplantation 1990; 50: 43.
14. Busing M, Holzner H, Schareck WD, et al. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial. Transplant Proc 1989; 21: 1601.
15. Isoniemi HM, Ahonen J, Tikkanen MJ, et al. Long-term consequences of different immunosuppressive regimens for renal allografts. Transplantation 1993; 55: 494.
16. Lindholm A, Albrechtsen D, Tufveson G, Karlberg I, Persson NH, Groth CG. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation. Transplantation 1992; 54: 624.
17. Ponticelli C, Tarantino A, Montagnino G, et al. A randomized trial comparing triple-drug and double-drug therapy in renal transplantation. Transplantation 1988; 45: 913.
18. Hardie IR, Tiller DJ, Mahony JF, et al. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+ prednisolone with cyclosporine+ azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee. Transplant Proc 1993; 25: 583.
19. Kootte AM, Lensen LM, van Bockell JH, Paul LC. A randomized study comparing high- and low-dose regimens of cyclosporine in renal transplantation. Transplant Proc 1988; 20: 136.
20. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Deciding on the best therapy. In: Clinical epidemiology: a basic science for clinical medicine. Boston: Little, Brown and Co, 1991: 187.
21. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Antithrombotic Therapy Concensus Conference. Chest 1992; 102: 305S.
22. Holman CDJ. Analysis of interobserver variation on a programmable computer. Am J Epidemiol 1984; 120: 154.
23. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408.
24. Isoniemi H, Ahonen J, Eklund B, et al. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression. Transpl Int 1990; 3: 121.
25. Montagnino G, Tarantino A, Banfi G, Aroldi A, Cesana B, Ponticelli C. A randomized trial comparing triple-drug and double-drug therapy in renal transplantation: analysis at 7 years. Transplantation 1994; 58: 149.
26. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of the disease. J Natl Cancer Inst 1959; 22: 719.
27. Breslow NE, Day NE. The analysis of case-control studies. In: Statistical methods in cancer research. Lyon, France: IARC Scientific Publications, 1980.
28. Almond PS, Matas A, Gillengham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
29. Gulanikar AC, MacDonald AS, Sungurtekin U, Belitsky P. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaveric kidney transplants. Transplantation 1992; 53: 323.
30. Cecka JM. Early rejection: determining the fate of renal transplants. Transplant Proc 1991; 23: 1263.
31. Kasiske BL, Heim-Duthoy K, Majz Z. Elective cyclosporine withdrawal after renal transplantation: a meta-analysis. JAMA 1993; 269: 395.
32. Oxman AD, Guyatt GH. A consumer's guide to subgroup analysis. Ann Intern Med 1992; 116: 78.
33. Canafax DM, Sutherland DER, Ascher NL, et al. Cyclosporine nephrotoxicity in renal allograft recipients: conversion to azathioprine to improve renal function. Transplant Proc 1983; 15: 2874.
34. Neumayer H-H, Luft FC, for the Transplantation Group of Central Frankonia. Twenty-five years of renal transplantation from a single center: a risk factor analysis for short- and long-term outcomes. Clin Invest 1993; 71: 341.